Repository logo
Communities & Collections
All of CIUDIR
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Emou, Frederick"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Determination of Glycosylated Haemoglobin Levels in Type II Diabetes Mellitus Patients on Different Drug Regimens at Mengo Referral Hospital.
    (International Health Sciences University., 2015-12) Emou, Frederick
    Introduction: Glycosylated haemoglobin has been known for some time as a critical marker in monitoring compliance to treatment by diabetic patients. With a single measurement, glycosylated haemoglobin can quantify average glycaemia over weeks and months, thereby complementing day to day testing. Glycosylated haemoglobin reflects a mean glycaemia over the preceding 2 to 3 months, measurement approximately every 3 months is required to determine whether a patient‟s metabolic control has reached and maintained within the target range. Glycosylated haemoglobin is not routinely used to monitor patients on treatment in MRH. Objectives: The main objective of the study was to determine the glycosylated haemoglobin levels in diabetic patients taking different drugs. Methodology: A cross-sectional study to measure glycosylated haemoglobin levels in diabetic patients who attended Diabetic clinic at Mengo Referral Hospital in Namirembe Rubaga division was carried out between August-October 2015 and 135 patients participated in the study. The method used to determine their HbA1c levels was using the Cobas Integra ® 400 Plus. In the Ethical consideration, the study was submitted to the; faculty, ethics, IHSU and MRH research committees for approval. Results: Out of the 135 participants, 57 (42.2%) were males and 78 (57.8%) were females. Only 26 (19.3%) of the participants had good glycaemic control (HbA1c <7.0%) and the rest had poor glycaemic control. Using multiple regression model, our study found out that, diabetic drugs had similar efficacy in achieving glycaemic control. Metformin was a better drug in achieving glycaemic control compared to insulin and glibenclamide. Conclusion: Most diabetic patients in Mengo hospital have poor glycaemic control. Metformin is a better drug in controlling hyperglycaemia and FBS is related to HbA1c Recommendation: HbA1c level should be adopted in monitoring diabetic patients on treatment as to detect and control their hyperglycaemia. A study with a bigger sample size from different diabetic clinics should be done to assess for the best drug to use in diabetic patients.

Clarke International University copyright © 2025

  • Privacy policy
  • End User Agreement
  • Send Feedback